The market is segmented based on , By Product Type (Assay Kits and Instruments), Application (Cancer Immunotherapy, Biomarker Discovery, Autoimmune Diseases, Vaccine Development and Efficacy, Transplant Rejection and Tolerance, Infectious Diseases and Other), End-User (Diagnostics Labs, Biotechnology and Pharmaceuticals Companies, Academic and Research Institutes and Others) – Industry Trends and Forecast to 2029.
.
The Global Immune Repertoire Sequencing Market size was valued at USD 149.54 USD Million in 2021.
The Global Immune Repertoire Sequencing Market is projected to grow at a CAGR of 6.95% during the forecast period of 2022 to 2029.
The major players operating in the market include Illumina Inc. , Thermo Fisher Scientific , PacBio , CD Genomics AGilent TechnologiesInc .,F. Hoffmann-La Roche Ltd , BGI Group Guangdong , Takara Bio Inc. , Adaptive Biotechnologies , AtrecaInc. ., iRepertoireInc. .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
Corporate Email ID Only (Avoid Using Generic mail ID such as Gmail)
Consent Preferences
We use cookies to improve your experience We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies. Cookie Notice.
The data presented is for visualization purposes only and may not reflect actual results.